William Blair Comments on Evolent Health Inc’s FY2019 Earnings (EVH)

Evolent Health Inc (NYSE:EVH) – Investment analysts at William Blair issued their FY2019 earnings per share estimates for Evolent Health in a research report issued on Wednesday. William Blair analyst R. Daniels expects that the technology company will post earnings per share of $0.03 for the year.

Evolent Health (NYSE:EVH) last announced its quarterly earnings data on Thursday, November 2nd. The technology company reported ($0.04) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.08) by $0.04. Evolent Health had a negative return on equity of 5.05% and a negative net margin of 15.86%. The firm had revenue of $107.90 million for the quarter, compared to analysts’ expectations of $104.49 million. During the same period last year, the business posted ($0.26) earnings per share. The firm’s revenue for the quarter was up 79.2% on a year-over-year basis.

EVH has been the topic of several other reports. Leerink Swann set a $25.00 target price on Evolent Health and gave the stock a “buy” rating in a research report on Saturday, November 18th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research report on Thursday, November 2nd. SunTrust Banks reaffirmed a “buy” rating and issued a $30.00 target price on shares of Evolent Health in a research report on Friday, November 3rd. KeyCorp initiated coverage on Evolent Health in a research report on Tuesday, September 19th. They issued an “overweight” rating and a $23.00 target price on the stock. Finally, Robert W. Baird reaffirmed an “outperform” rating and issued a $25.00 target price (down from $35.00) on shares of Evolent Health in a research report on Tuesday, September 26th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and thirteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $28.00.

Shares of Evolent Health (NYSE:EVH) traded up $0.45 during midday trading on Monday, reaching $15.05. The company’s stock had a trading volume of 1,498,800 shares, compared to its average volume of 1,200,967. Evolent Health has a 1 year low of $10.30 and a 1 year high of $27.50. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.34 and a quick ratio of 3.34. The firm has a market capitalization of $1,160.00 and a price-to-earnings ratio of -13.20.

Several institutional investors and hedge funds have recently modified their holdings of the company. ETF Managers Group LLC acquired a new position in shares of Evolent Health during the second quarter valued at $102,000. BNP Paribas Arbitrage SA increased its holdings in shares of Evolent Health by 815.4% during the second quarter. BNP Paribas Arbitrage SA now owns 4,751 shares of the technology company’s stock valued at $120,000 after purchasing an additional 4,232 shares during the period. Legal & General Group Plc increased its holdings in shares of Evolent Health by 122.4% during the second quarter. Legal & General Group Plc now owns 9,846 shares of the technology company’s stock valued at $250,000 after purchasing an additional 5,418 shares during the period. Grandeur Peak Global Advisors LLC increased its holdings in shares of Evolent Health by 58.6% during the third quarter. Grandeur Peak Global Advisors LLC now owns 19,625 shares of the technology company’s stock valued at $349,000 after purchasing an additional 7,250 shares during the period. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Evolent Health by 245.2% during the second quarter. PNC Financial Services Group Inc. now owns 10,357 shares of the technology company’s stock valued at $262,000 after purchasing an additional 7,357 shares during the period. 95.38% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “William Blair Comments on Evolent Health Inc’s FY2019 Earnings (EVH)” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/15/william-blair-comments-on-evolent-health-incs-fy2019-earnings-evh.html.

Evolent Health Company Profile

Evolent Health, Inc is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models.

Earnings History and Estimates for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply